Veracyte (VCYT) Tops Q3 EPS by 19c, provides guidance

Veracyte (NASDAQ: VCYT) reported Q3 EPS of $0.51, $0.19 better than the analyst estimate of $0.32. Revenue for the quarter came in at $131.9 million versus the consensus estimate of $124.78 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $506-510 million, versus the consensus of $500.2 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Doncasters Group guiding IPO pricing at top of range - Bloomberg
• Blackstone to invest $30B in AI data centers in Japan over the next 3 to 5 years, says president and COO Jonathan Gray - Nikkei